Skip to content

Clinical Efficacy Evaluation of Qingke Mixture in the Treatment of Mycoplasma Pneumonia in Children

Clinical Efficacy Evaluation of Qingke Mixture in the Treatment of Mycoplasma Pneumonia in Children

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000355
Enrollment
Unknown
Registered
2024-09-02
Start date
2024-01-11
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infantile pneumonia

Interventions

treatment group:Clearing cough mixture combined with azithromycin

Sponsors

The Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for mycoplasma pneumonia in children 1= age =14 years old; 2. There were obvious clinical symptoms of irritating cough and chest imaging examination supported the diagnosis; 3. Serum Mycoplasma pneumoniae specific antibody IgM or IgG test was positive; 4. The child can actively cooperate with the completion of treatment and the child's family members sign a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Concurrent with other respiratory infections; 2. Damage of liver and kidney function; 3. Unable to cooperate with medical staff in related diagnosis and treatment during treatment; 4. Test patients with drug allergy; 5. Patients with severe digestive or blood system abnormalities; 6. Recent treatment with immunosuppressants and other antibiotics.

Design outcomes

Primary

MeasureTime frame
Clinical symptoms: cough, phlegm, sore throat, fever, headache, body temperature, heart rate, respiratory rate.;

Secondary

MeasureTime frame
Immune indicators: immune globulin IgM IgA IgG; Immune cells CD4 CD8.;Inflammatory markers: C-reactive protein white blood cell count erythrocyte sedimentation rate IL-6 IL-8 CO2 concentration.;Adverse reactions: allergies drug side effects etc. Whether the patient has complications such as respiratory distress pneumonia etc.;

Countries

China

Contacts

Public ContactXiao-fei Xie

The Affiliated Hospital of Changchun University of Traditional Chinese Medicine

390029712@qq.com13604404047

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026